Ive been told that this was a planned safety review by the DSMC, and NOT a review for effectiveness. The effectiveness review is what would likely halt the trial if they see an overwhelmingly clear benefit. Apparently halting the trial for said benefit is extremely rare even when the results are good, in the safety review.

I say this changes nothing and they were still where we were at 3:59 EST and all remains intact. This stock could explode at any time. All systems GO